Please wait while your page loads ...
FARA
Cure FA
TALEs targeting a promoter sequence and fused with a transcription activation domain (TAD) may be used to specifically induce the expression of a gene as a potential treatment for haploinsufficiency. This potential therapeutic approach was applied to increase the expression of frataxin in fibroblasts of Friedreich ataxia (FRDA) patients.
Archived in
2019 (38) June (6)
May (5)
April (5)
March (7)
February (8)
January (7)
2018 (68) December (5)
November (7)
October (6)
September (5)
August (6)
July (7)
June (5)
May (5)
April (3)
March (9)
February (3)
January (7)
2017 (79) December (8)
November (5)
October (16) September (6)
August (10) July (6)
June (2)
May (8)
April (3)
March (4)
February (4)
January (7)
2016 (87) December (3)
November (4)
September (9)
August (9)
July (9)
June (3)
May (11) April (11) March (4)
February (8)
January (16) 2015 (72) December (2)
November (2)
September (8)
August (12) July (3)
June (11) April (10) March (7)
February (11) January (6)
2014 (70) December (5)
November (3)
October (7)
September (10) August (11) June (5)
May (10) April (5)
March (4)
February (4)
January (6)
2013 (72) December (4)
October (3)
September (17) August (2)
July (4)
June (9)
May (1)
April (10) March (14) February (5)
January (3)
2012 (14) December (8)
November (5)
October (1)
Tagged in